Today, researchers are studying safe and effective drugs to overcome the destructive effects of insulin-related metabolic disorders, including hyperglycemia, hyperinsulinemia, hyperlipidemia, oxidative stress, inflammation, atherosclerosis, and other complications. This evidence concerns the gene INS and hyperlipidemia.